Krebs Biochemicals and Industries Limited — Others, 04-02-2025: Change in Director(s)

Krebs Biochemicals & Industries Limited has announced a board meeting to review its unaudited financial results for the third quarter and nine months ended December 31, 2024. The results indicate significant losses, totaling Rs 1,972.84 lakh for the nine months. In governance updates, the board has appointed Mr. Popatlal Mukanchand Kathariya, Ms. Dipti Chinubhai Shah, Mr. Satya Prakash Chigurupati, and Mr. Sumanth Karlapudi as Additional and Independent Directors for a five-year term, enhancing board expertise. This move may foster a positive outlook among investors, reflecting a commitment to strong governance and potential for strategic growth.